ATE303819T1 - Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten - Google Patents
Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheitenInfo
- Publication number
- ATE303819T1 ATE303819T1 AT01983771T AT01983771T ATE303819T1 AT E303819 T1 ATE303819 T1 AT E303819T1 AT 01983771 T AT01983771 T AT 01983771T AT 01983771 T AT01983771 T AT 01983771T AT E303819 T1 ATE303819 T1 AT E303819T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- prevent
- autoimmune diseases
- medicinal product
- long pentraxin
- Prior art date
Links
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 title abstract 3
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 title abstract 3
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 title abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000RM000571A IT1317927B1 (it) | 2000-11-03 | 2000-11-03 | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
PCT/IT2001/000530 WO2002036151A2 (en) | 2000-11-03 | 2001-10-18 | Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE303819T1 true ATE303819T1 (de) | 2005-09-15 |
Family
ID=11454977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01983771T ATE303819T1 (de) | 2000-11-03 | 2001-10-18 | Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040029803A1 (de) |
EP (1) | EP1370279B1 (de) |
JP (1) | JP4105542B2 (de) |
KR (1) | KR100812805B1 (de) |
CN (1) | CN1326563C (de) |
AT (1) | ATE303819T1 (de) |
AU (2) | AU1518902A (de) |
BR (1) | BR0115050A (de) |
CA (1) | CA2427533A1 (de) |
CZ (1) | CZ297242B6 (de) |
DE (1) | DE60113304T2 (de) |
DK (1) | DK1370279T3 (de) |
ES (1) | ES2248401T3 (de) |
HK (1) | HK1071291A1 (de) |
HU (1) | HUP0401593A2 (de) |
IT (1) | IT1317927B1 (de) |
MX (1) | MXPA03003805A (de) |
PL (1) | PL365291A1 (de) |
SK (1) | SK5332003A3 (de) |
WO (1) | WO2002036151A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
ITRM20020109A1 (it) * | 2002-02-28 | 2003-08-28 | Sigma Tau Ind Farmaceuti | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
JP5339676B2 (ja) * | 2003-02-21 | 2013-11-13 | メドベット サイエンス ピーティーワイ. リミテッド | 細胞を検出する方法、およびこれに有用な薬剤 |
ITRM20030596A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
ITRM20030595A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile. |
ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
EP1832295A1 (de) * | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Verwendung von PTX3 zur Behandlung viraler Erkrankungen |
CA2649063C (en) | 2006-05-02 | 2014-11-25 | Luigina Romani | Use of thymosin .alpha.1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection |
KR101305515B1 (ko) | 2011-06-10 | 2013-09-06 | 경북대학교 산학협력단 | 펜트락신 3 단백질의 파킨슨 질환 진단 용도 |
US20150299277A1 (en) * | 2012-06-22 | 2015-10-22 | The University Of Tokyo | Agent for treating or preventing systemic inflammatory response syndrome |
CN105903001A (zh) * | 2016-05-09 | 2016-08-31 | 中国科学院海洋研究所 | 一种鱼类穿透素的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
US6013217A (en) * | 1997-12-22 | 2000-01-11 | Dow Corning Corporation | Method for extruding thermoplastic resins |
-
2000
- 2000-11-03 IT IT2000RM000571A patent/IT1317927B1/it active
-
2001
- 2001-10-18 WO PCT/IT2001/000530 patent/WO2002036151A2/en active IP Right Grant
- 2001-10-18 PL PL01365291A patent/PL365291A1/xx unknown
- 2001-10-18 BR BR0115050-2A patent/BR0115050A/pt not_active IP Right Cessation
- 2001-10-18 US US10/415,413 patent/US20040029803A1/en not_active Abandoned
- 2001-10-18 CZ CZ20031043A patent/CZ297242B6/cs not_active IP Right Cessation
- 2001-10-18 MX MXPA03003805A patent/MXPA03003805A/es active IP Right Grant
- 2001-10-18 AU AU1518902A patent/AU1518902A/xx active Pending
- 2001-10-18 KR KR1020037005650A patent/KR100812805B1/ko not_active IP Right Cessation
- 2001-10-18 ES ES01983771T patent/ES2248401T3/es not_active Expired - Lifetime
- 2001-10-18 SK SK533-2003A patent/SK5332003A3/sk not_active Application Discontinuation
- 2001-10-18 AT AT01983771T patent/ATE303819T1/de not_active IP Right Cessation
- 2001-10-18 AU AU2002215189A patent/AU2002215189B2/en not_active Ceased
- 2001-10-18 DE DE60113304T patent/DE60113304T2/de not_active Expired - Fee Related
- 2001-10-18 CA CA002427533A patent/CA2427533A1/en not_active Abandoned
- 2001-10-18 CN CNB018182984A patent/CN1326563C/zh not_active Expired - Fee Related
- 2001-10-18 HU HU0401593A patent/HUP0401593A2/hu unknown
- 2001-10-18 JP JP2002538961A patent/JP4105542B2/ja not_active Expired - Fee Related
- 2001-10-18 EP EP01983771A patent/EP1370279B1/de not_active Expired - Lifetime
- 2001-10-18 DK DK01983771T patent/DK1370279T3/da active
-
2005
- 2005-05-13 HK HK05104020A patent/HK1071291A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1317927B1 (it) | 2003-07-15 |
JP4105542B2 (ja) | 2008-06-25 |
BR0115050A (pt) | 2003-09-30 |
AU2002215189B2 (en) | 2006-08-03 |
WO2002036151A3 (en) | 2003-10-16 |
AU1518902A (en) | 2002-05-15 |
CZ20031043A3 (cs) | 2003-09-17 |
DE60113304D1 (de) | 2005-10-13 |
HK1071291A1 (en) | 2005-07-15 |
ITRM20000571A0 (it) | 2000-11-03 |
KR100812805B1 (ko) | 2008-03-12 |
WO2002036151A2 (en) | 2002-05-10 |
SK5332003A3 (en) | 2003-12-02 |
MXPA03003805A (es) | 2004-04-20 |
EP1370279A2 (de) | 2003-12-17 |
DE60113304T2 (de) | 2006-06-08 |
CZ297242B6 (cs) | 2006-10-11 |
ITRM20000571A1 (it) | 2002-05-03 |
CA2427533A1 (en) | 2002-05-10 |
HUP0401593A2 (hu) | 2004-12-28 |
US20040029803A1 (en) | 2004-02-12 |
JP2004512372A (ja) | 2004-04-22 |
CN1326563C (zh) | 2007-07-18 |
PL365291A1 (en) | 2004-12-27 |
ES2248401T3 (es) | 2006-03-16 |
EP1370279B1 (de) | 2005-09-07 |
KR20030060918A (ko) | 2003-07-16 |
DK1370279T3 (da) | 2006-01-23 |
CN1561226A (zh) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908219A (pt) | Pró-perfumes cìclos tendo taxas de liberação de matéria-prima de álcool com fragrância modificável | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
ATE172641T1 (de) | Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
DE59006880D1 (de) | Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin. | |
HK1071291A1 (en) | User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies | |
EE200200717A (et) | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid | |
DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
ATE274349T1 (de) | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs | |
DE69713484D1 (de) | Verwendung von ginkgo biloba extrakten zur herstellung von pharmazeutischen zusammenstellungen | |
DE69805096D1 (de) | Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments | |
BRPI0418138A (pt) | medicamento compreendendo ptx3, sozinho ou em combinação com tsg-6, para tratar doenças degenerativas de cartilagem e ósseas e tratar infertilidade feminina | |
BR9812531A (pt) | Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica | |
HUP0301831A2 (hu) | Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére | |
DE69531554D1 (de) | Verwendung von inosittriphosphat zur herstellung von arzneimitteln | |
DE69720064D1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
HUP9701284A2 (hu) | 2,3-Benzodiazepin-származékok felhasználása az endogén opioid rendszerrel összefüggő betegségek és állapotok kezelésére, és megelőzésére alkalmas gyógyászati készítmények előállítására | |
ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
DE69011857D1 (de) | Verwendung von GnRH-analog zur Herstellung eines Arzneimittels zur Behandlung von Motilitätsstörungen. | |
ES2160927T3 (es) | Composiciones farmaceuticas que comprenden interferon alfa humano natural. | |
KR970058708A (ko) | 엘-무스콘(l-muscone)의 의약용도 | |
AU2001278344A1 (en) | Use of extracts from ginkgo biloba leaves for inducing dreams |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1370279 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |